Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenues $ 2,101 $ 10,147
Cost of goods sold 967 9,956
Gross profit 1,134 191
Operating expenses:    
General and administrative 347,297 381,383
Professional fees 103,848 171,050
Depreciation expense 7,857 12,485
Total operating expenses 459,002 564,918
Operating loss (457,868) (564,727)
Other income (expense):    
Gain on early extinguishment of debt 121,372
Interest income 41
Interest expense (58,070) (166,192)
Total other expense (58,070) (44,779)
Net loss (515,938) (609,506)
Other comprehensive loss:    
Gain on foreign currency translation 184,969 16,804
Net other comprehensive loss (330,969) (592,702)
Series A convertible preferred stock declared ($0.60 per share) (12,773) (10,258)
Net loss attributable to common shareholders $ (343,742) $ (602,960)
Weighted average number of common shares outstanding - basic and diluted 68,702,907 65,605,389
Net loss per share - basic and diluted $ (0.01) $ (0.01)
Dividends declared per share of common stock $ 0.00 $ 0.00